Zacks Investment Research on MSN
3 stocks likely to gain from rising HSA contribution & Medicare premium
As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...
As the year comes to a close, it's time to look back at the numerous innovations across the diabetes technology industry in ...
Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on ...
During Q3, Harbor Transformative Technologies ETF returned 10.15%, outperforming its benchmark, the Nasdaq 100 Total Return ...
Maintaining sterile packaging for CGMs is critical to patient safety. Explore advanced methods like vacuum decay and airborne ...
DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...
SIGN UP FOR THE AT: https://www.ktmc.com/new-cases/dexcom-inc-1?utm_source=NewMediaWire&mktm=PR ...
Please CLICK HERE to view our video or copy and paste this link into your browser: https://youtube.com/shorts/ToTm4-K0ODs?feature=share ...
Abstract: Continuous health monitoring by placing sensors onto and into the human body has emerged as a pivotal approach in healthcare. This paper delves into the vast array of opportunities presented ...
Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” third-quarter 2025 ...
Kessler Topaz Meltzer & Check, LLP encourages DexCom investors who have suffered significant losses to contact the firm directly to acquire more information. SIGN UP FOR THE AT: ...
Zacks Investment Research on MSN
Here's why you should hold DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results